Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$48.88 +0.77 (+1.60%)
At close: Oct 21, 2026 · 4:00 PM EDT

Rigel Pharmaceuticals (RIGL) Restructuring Costs (2013 - 2016)

Updated

Rigel Pharmaceuticals' Restructuring Costs was $1.32 million in FY2022, down 62.5% from $3.52 million in FY2021.

Analysis

Rigel Pharmaceuticals (RIGL) Restructuring Costs (2013 - 2016) Analysis & Trends

From FY2009 onward, Rigel Pharmaceuticals has reported Restructuring Costs for 5 years.

  • The FY2022 figure marks the lowest annual Restructuring Costs since FY2009.
  • Per Business Quant data, Restructuring Costs in earlier years was $3.52 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Rigel Pharmaceuticals 906.93 Mn 372.82 Mn 70.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 5.77 Mn
Sep 30, 2013 1.70 Mn
API Access

Rigel Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=RIGL&period=max&api_key=YOUR_API_KEY